OM logo

OUTSET MEDICAL INC

OMNASDAQ
🏆 #4414 by market capUS Equity
$3.02▲ $0.06 (+2.03%)
Market closed · at close
🔔
Track OM
Get earnings, price moves & breaking news on Telegram
Track
24h▲ 2.0%
7d▼ 3.0%
14d▼ 3.4%
30d▼ 20.5%
ytd▼ 18.8%
1y▼ 78.6%
🏦Market Cap
$56M
Small Cap
📈Revenue Growth (YoY)
+5.1%
Slowing
📊Gross Margin
41.8%
Healthy
💵FCF Margin
-33.0%
Thin
⚖️P/S Ratio
0.5x
Cheap
Otter Score
48
Weak

Trading Snapshot

Day Range
$2.98 – $3.06
52-Week Range
$2.84 – $16.16
Volume
$3.95B
Avg Volume
$3.86B
Shares Outstanding
18.5M
Next Earnings
Dec 5, 2026

Fundamentals Snapshot

Annual Revenue
$119M
Last Q Revenue
$32M
P/E Ratio
-0.7
P/S Ratio
0.5x
EPS (TTM)
$-3.99
Dividend Yield
0.00%
Dilution (1yr)
+421.7%

Why Investors Own OM

  • ✓High-growth profile — revenue up +58.2% YoY with expanding US Equity exposure.
  • ✓Healthy economics — 42% gross margin and 23% free-cash-flow margin.
  • ✓New products and segments could unlock additional revenue streams.
⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

OM logo

OUTSET MEDICAL INC

OM
Financial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$119M▲ +5.1% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
39.1%▲ +15.4% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
−$67M▼ −41.2% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
−$47M▼ −59.8% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
17.8M▲ +421.7% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
−$66M▲ +$12M YoY
StockOtter · stockotter.space

About OUTSET MEDICAL INC

Outset Medical, Inc. is a medical technology firm that specializes in developing hemodialysis systems. The company's primary product is the Tablo Hemodialysis System, a compact console designed to deliver dialysis treatment in various environments, including hospitals and patients' homes. This innovative system boasts integrated water purification, on-demand production of dialysate, and advanced software complete with connectivity features. Founded in 2003, the company initially operated under the name Home Dialysis Plus, Ltd. before rebranding to Outset Medical, Inc. in January 2015. Its corporate headquarters are located in San Jose, California.

🦦

Otter Score Breakdown

How it's scoredFive components, each rated 1–5★ and equally weighted (20%), averaged to a 0–100 score:💎 Quality — gross margin🚀 Growth — revenue YoY⚖️ Valuation — P/S ratio⚡ Momentum — 30-day price change💧 Dilution — 1-yr share issuance (buybacks score higher)
💎Quality★★★★★
🚀Growth★★★★★
⚖️Valuation★★★★★
⚡Momentum★★★★★
💧Dilution★★★★★
Overall Score
Weak
48/100

Analyst Price Target

ⓘ
Average Target
$3.19
▲ +5.5% Upside
High Target$3.69
Low Target$2.84
Based on 34 analysts

Latest News & Updates

🚀
CNBC·2h ago

OUTSET MEDICAL INC tops quarterly estimates as demand accelerates

Revenue grew double digits with management guiding above consensus; margins continued to expand.

🛰️
Barron’s·5h ago

Analysts lift OM price targets on improving margins

Several firms raised targets, citing stronger free cash flow and a healthier backlog.

🌌
MarketWatch·1d ago

OUTSET MEDICAL INC announces new agreement to expand its footprint

The move broadens the company’s reach and could add incremental revenue over the next year.